Moreover, LINC00092 was demonstrated to promote the glycolysis of tumor cells and induce the metastasis of ovarian cancer cells by enhancing the expression of glycolytic enzyme PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2) and combining with it (130). Here, PFKFB2 is linked to ovarian cancer.